Objective The aim of this study is to compare the effect of ethinyl estradiol 0.03
mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg …

OBJECTIVE: To compare the effect of ethinyl estradiol 20 μg/drospirenone 3 mg (EE 20
μg/DRSP 3 mg) administered according to a 24/4 regimen with ethinyl estradiol 20 …

This study was conducted to compare the cycle control, efficacy and adverse events of a
new low-dose oral contraceptive pill regimen containing 3 mg drospirenone (DRSP)/30 μg …

Objective: The purpose of this study was to assess the efficacy and safety of a new low-dose
oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg (EE 20μg/drsp …

Objective The effects of estetrol (E4), a natural fetal estrogen, combined with drospirenone
(DRSP) were evaluated on plasma levels of sex hormone-binding globulin (SHBG) …

This prospective, open, randomized study was conducted to compare the contraceptive
reliability, cycle control, and tolerability of a 23-day regimen with 20 μg ethinyl estradiol (EE) …

PURPOSE: In this open-label, randomized study, we assessed the effects on hemostasis of
two combined oral contraceptives containing drospirenone (DRSP) as progestogen …

The effects of a combined oral contraceptive (COC) containing 20 μg ethinyl estradiol (EE)
and 75 μg gestodene (GSD) on prothrombin activity (PA), activated partial thromboplastin …

The effect of a triphasic oral contraceptive containing ethinyl estradiol and gestodene
(EE/GSD) on various lipid and lipoprotein parameters was compared with that of a …

Objectives To assess the contraceptive efficacy, bleeding pattern and safety of a combined
oral contraceptive containing estetrol (E4) 15 mg and drospirenone (DRSP) 3 mg. Design …